Common Contracts

Representing 33,600,000 Ordinary Shares (Par Value £0.001 Per Share) GW PHARMACEUTICALS PLC UNDERWRITING AGREEMENT

Gw Pharmaceuticals PLC • July 14th, 2016 • Pharmaceutical preparations • New York

• Company
  Gw Pharmaceuticals PLC
• Filed
  July 14th, 2016
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Introduction. GW Pharmaceuticals plc, a company incorporated in England and Wales (the “Company”) proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 2,800,000 American Depositary Shares (“ADSs” and, such ADSs, the “Firm ADSs”), each representing 12 ordinary shares, par value £0.001 per share, of the Company (the “Ordinary Shares”). The ADSs will be evidenced by American Depositary Receipts (“ADRs”) issued pursuant to that certain Deposit Agreement dated May 7, 2013 (the “Deposit Agreement”), by and among the Company, Citibank, N.A., as depositary (the “Depositary”), and all holders and beneficial owners of ADSs issued thereunder. The Ordinary Shares to be issued in connection with, and represented by, the ADSs are hereinafter referred to as the “Underlying Securities.”

1,700,000 American Depositary Shares Representing 20,400,000 Ordinary Shares (Par Value £0.001 Per Share) GW PHARMACEUTICALS PLC UNDERWRITING AGREEMENT

Gw Pharmaceuticals PLC • June 20th, 2014 • Pharmaceutical preparations • New York

• Company
  Gw Pharmaceuticals PLC
• Filed
  June 20th, 2014
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Introduction. GW Pharmaceuticals plc, a company incorporated in England and Wales (the “Company”), and certain shareholders of the Company (the “Selling Shareholders”) named in Schedule I hereto severally propose to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of 1,700,000 American Depositary Shares (“ADSs” and, such ADSs, the “Firm ADSs”), each representing 12 ordinary shares, par value £0.001 per share, of the Company (the “Ordinary Shares”), of which 1,200,000 ADSs are to be issued and sold by the Company and 500,000 ADSs are to be sold by the Selling Shareholders, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule I hereto.

American Depositary Shares Representing [_______] Ordinary Shares (Par Value £0.001 Per Share) GW PHARMACEUTICALS PLC UNDERWRITING AGREEMENT

Gw Pharmaceuticals PLC • January 6th, 2014 • Pharmaceutical preparations • New York

• Company
  Gw Pharmaceuticals PLC
• Filed
  January 6th, 2014
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

The ADSs will be evidenced by American Depositary Receipts (“ADRs”) issued pursuant to that certain Deposit Agreement dated May 7, 2013 (the “Deposit Agreement”), by and among the Company, Citibank, N.A., as depositary (the “Depositary”), and all holders and beneficial owners of ADSs issued thereunder. The Ordinary Shares to be issued in connection with, and represented by, the ADSs are hereinafter referred to as the “Underlying Securities.”